About 25000 IU- 5 Ml Heparin Injection IP
Heparin Injection IP, presenting a prodigious 25000 IU in a 5 ml glass ampoule, offers brilliant anticoagulant effectiveness for the prevention and treatment of blood clots. This clear, colorless to pale yellow solution, approved under IP standards and marketed across India, ensures soaring savings without compromising safety or quality. Its flexible administration-either intravenously or subcutaneously-makes it a bargain for hospitals and healthcare providers. Each ampoule contains Heparin Sodium, delivering measurable benefits for patients at risk of thrombosis, with responsive support from trusted distributors, exporters, and suppliers.
Heparin Injection IP: Application & Competitive Advantages
Suitable for adults and the elderly, Heparin Injection IP shines in both prevention and treatment of blood clots-including deep vein thrombosis and pulmonary embolism. Its competitive advantages include a consistent anticoagulant effect, adherence to IP regulatory standards, and ease of administration, making it an essential therapeutic tool in hospitals. Recommended for use in clinical settings, this product supports superior patient outcomes and delivers value in both acute and chronic care environments.
Domestic Market Delivery & Supply Credentials
Heparin Injection IP is delivered reliably throughout the Indian market, with supply ability tailored to large-scale healthcare demand. Certifications under the Indian Pharmacopoeia (IP) standard raise its market value and ensure safety and consistency. Distributors and exporters estimate prompt availability, as the product is consistently stocked to meet hospital and clinic requirements. The main domestic market includes major cities and regions across India, reflecting the high trust and broad medical acceptance for this critical anticoagulant.
FAQ's of 25000 IU- 5 Ml Heparin Injection IP:
Q: How should Heparin Injection IP 25000 IU - 5 ml be administered?
A: Heparin Injection IP is typically administered either intravenously (IV) or subcutaneously (SC) by healthcare professionals, strictly following a physician's dosage instructions.
Q: What is the primary benefit of using Heparin Injection IP?
A: The primary benefit is its effectiveness in preventing and treating blood clots such as deep vein thrombosis, pulmonary embolism, and arterial thromboembolism, thus reducing the risk of potentially serious complications.
Q: When is Heparin Injection IP recommended for use?
A: It is recommended for adults and elderly patients for both the prevention and treatment of venous and arterial thrombosis. In children, it is given only under specific medical guidance.
Q: Where should Heparin Injection IP be stored for maximum effectiveness?
A: The ampoules should be stored below 25C, protected from light, and must not be frozen to maintain their quality and potency.
Q: What precautions should be followed during the usage of Heparin Injection IP?
A: Precautions include not administering intramuscularly, regular monitoring of platelet counts to detect Heparin-Induced Thrombocytopenia (HIT), and using caution in patients with bleeding disorders.
Q: How does the supply process of Heparin Injection IP ensure reliability?
A: Heparin Injection IP is distributed by various certified pharmaceutical suppliers across India, ensuring timely and efficient delivery to hospitals and clinics, backed by regulatory approvals.